Regeneron Pharmaceuticals, Inc. REGN

788.04 (7.98) (1.00%) as of 25 Sep
Market cap
$81.3B
P/E
18.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
45.15 33.92 16.50 19.38 14.75 8.26 17.78 24.43 17.42 17.90
P/S ratio
8.18 6.93 7.83 6.25 6.12 4.15 6.34 7.36 5.41 5.63
P/FCF ratio
40.82 39.31 22.24 20.50 25.95 10.22 22.71 26.33 21.60 21.44
P/Operating CF
101.83 71.74 55.30 52.07 42.23 28.14 44.86 88.61 60.87 68.97
P/B ratio
8.94 6.62 4.60 3.70 4.71 3.56 3.40 3.72 2.62 2.58
Price to Tangible BV
8.94 6.62 4.60 3.70 4.71 3.56 3.55 3.87 2.73 2.69
EV/Sales
8.04 6.81 7.42 5.87 6.19 3.97 5.98 6.80 5.02 5.27
EV/EBITDA
27.22 17.96 14.24 15.91 13.79 6.91 14.34 19.95 15.93 18.33
EV/Operating CF
26.29 30.57 17.40 15.84 20.09 9.00 14.53 19.40 16.12 15.18
EV/FCF
40.11 38.63 21.08 19.25 26.25 9.76 21.44 24.31 20.03 20.07
Quick Ratio
2.13 2.98 3.50 2.86 2.86 2.98 4.16 4.82 3.86 3.28
Current Ratio
2.56 3.82 4.47 3.67 3.63 3.56 5.06 5.69 4.73 4.13
Net Debt/EBITDA
(0.48) (0.32) (0.78) (1.03) (0.23) (0.40) (0.99) (1.82) (1.41) (1.43)
Debt/Assets
5.04% 8.03% 6.04% 4.82% 15.71% 7.78% 9.25% 8.17% 7.16% 6.67%
Debt/Equity
0.08 0.11 0.08 0.06 0.24 0.11 0.12 0.10 0.09 0.09
Asset Turnover
0.77 0.75 0.50 0.49 0.53 0.75 0.45 0.42 0.40 0.37
Operating CF/Net income
1.66 1.09 0.90 1.15 0.75 0.88 1.16 1.16 1.00 1.11
Capex/Depreciation
(4.89) (1.87) (2.58) (2.04) (2.61) (1.93) (4.74) (2.20) (1.78) (2.23)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
22.10% 22.63% 32.81% 21.32% 31.77% 54.21% 20.94% 16.26% 15.95% 14.87%
ROA
14.23% 15.23% 23.85% 15.94% 21.98% 37.91% 15.88% 12.69% 12.46% 11.50%
ROIC
22.11% 23.90% 23.80% 16.08% 22.06% 37.14% 16.81% 14.19% 10.82% 8.82%
Return on Tangible Assets
22.26% 21.56% 32.25% 24.94% 34.10% 59.53% 26.28% 19.57% 22.84% 24.00%
Average Days of Receivables
121.03 122.72 159.12 155.05 176.75 137.09 159.78 157.70 159.65 146.10
Research and Development Expense of Revenue
42.22% 35.34% 28.54% 37.36% 31.15% 17.80% 29.51% 33.84% 36.14% 40.79%
Selling, General and Administrative Expense of Revenue
24.23% 22.49% 21.91% 20.46% 15.84% 11.35% 17.38% 20.06% 20.80% 18.82%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.03
Share Based Compensation of Revenue
11.52% 8.64% 8.31% 7.08% 5.08% 3.74% 5.96% 6.75% 6.92% 6.93%
Graham Net Nets
0.02 0.04 0.09 0.10 0.07 0.11 0.12 0.13 0.13 0.11
Graham Number
89.67 121.12 203.33 210.38 274.82 552.66 439.24 450.47 500.23 538.44
Earnings Yield
2.21% 2.95% 6.06% 5.16% 6.78% 12.11% 5.62% 4.09% 5.74% 5.59%
Free Cash Flow Yield
2.45% 2.54% 4.50% 4.88% 3.85% 9.78% 4.40% 3.80% 4.63% 4.66%
Revenue per Share
46.42 55.24 47.69 60.05 78.97 152.05 113.66 122.94 131.62 137.12
Operating CF per Share
14.19 12.30 20.34 22.25 24.33 66.99 46.82 43.06 40.97 47.60
Capex per Share
(4.89) (2.56) (3.55) (3.93) (5.71) (5.22) (15.10) (8.68) (7.98) (11.60)
Free Cash Flow per Share
9.30 9.73 16.79 18.32 18.62 61.77 31.73 34.37 32.98 36.00
Cash per Share
9.92 13.26 26.04 29.44 33.34 53.88 72.29 101.64 83.53 82.27
Shareholders Equity per Share
42.50 57.80 81.16 101.55 102.47 177.57 211.62 243.42 272.04 298.82
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
42.50 57.80 81.16 101.55 102.47 177.57 211.62 243.42 272.04 298.82
Free Cash Flow
974.00 1,034.50 1,812.00 2,000.40 2,003.50 6,529.40 3,398.00 3,667.60 3,559.00 3,765.20
Working Capital
1,938.69 3,199.50 5,004.80 5,592.50 7,081.70 10,082.40 12,742.80 16,055.80 14,716.60 13,653.50
Capital Expenditures
(511.90) (272.60) (383.10) (429.60) (614.60) (551.90) (1,616.90) (926.40) (861.50) (1,213.70)
Net Current Asset Value
655.97 1,714.80 3,470.40 3,973.60 3,641.10 7,348.90 9,333.60 12,372.10 10,255.10 8,720.10
EV/EBIT
29.36 19.22 15.07 17.42 14.70 7.13 15.37 22.03 17.86 21.12
Capex to Sales
0.11 0.05 0.07 0.07 0.07 0.03 0.13 0.07 0.06 0.08
Net Profit Margin
18.42% 20.41% 47.50% 32.26% 41.35% 50.25% 35.64% 30.14% 31.07% 31.41%
Price to Operating Income
29.87 19.56 15.90 18.55 14.53 7.46 16.28 23.86 19.26 22.57
Other line items
Depreciation/Fixed assets
0.05 0.06 0.06 0.07 0.07 0.08 0.09 0.10 0.11 0.11
Cash ROIC
(10.23%) (12.73%) (3.10%) (3.07%) (3.49%) 13.61% 3.78% 1.13% (0.44%) (0.33%)
Accounts Receivable Turnover
3.16 3.28 2.44 2.61 2.46 3.17 2.14 2.39 2.39 2.40
Accounts Payable Turnover
0.39 0.75 2.11 2.40 2.51 4.69 2.71 3.04 2.82 2.43
Inventory Turnover
0.94 0.71 0.44 0.60 0.67 1.26 0.72 0.73 0.70 0.67
Average Days of Payables
1,070.64 163.80 190.76 199.46 154.98 84.46 137.82 121.93 146.24 163.15
Days of Inventory on Hand
486.37 667.40 1,006.44 675.28 624.66 292.19 561.84 518.71 571.87 556.14
Average Receivables
1,539.71 1,792.96 2,108.75 2,514.40 3,450.15 5,075.60 5,682.60 5,498.00 5,939.60 5,976.50
Average Payables
761.60 528.65 198.20 318.15 446.80 519.75 576.60 597.90 698.05 864.25
Average Inventory
318.97 562.73 938.65 1,283.35 1,666.05 1,933.95 2,176.60 2,491.20 2,833.90 3,144.05
Average Assets
6,291.30 7,868.88 10,249.40 13,269.85 15,984.25 21,299.05 27,324.65 31,147.35 35,419.80 39,159.05
Average Common Equity
4,052.04 5,296.67 7,450.70 9,923.50 11,057.50 14,897.05 20,716.40 24,318.55 27,663.35 30,305.25

Fold the line items

Columns are period end dates